$15.01
At close: Nov 6 EDT
$14.85
-0.16-1.07%
Pre-Market: 5:28 PM EDT
Comments
Loading...
CareDx Earnings Estimates, EPS & Revenue | NASDAQ:CDNA | Benzinga
CareDx reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 4
EPS
$0.280
Quarterly Revenue
$100.06M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$358.00M
Analyze the earnings history of CareDx using advanced sorting and filters.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
CDNA | CareDx | $0.14 | $0.04 | $0.28 | 600.00% | $82.88M | $95.24M | $100.06M | 5.05% | 11/04/2025 | |
CDNA | CareDx | $0.25 | $0.03 | $0.10 | 233.33% | $92.27M | $90.63M | $86.68M | -4.35% | 08/06/2025 | |
CDNA | CareDx | -$0.03 | $0.07 | $0.09 | 28.57% | $72.05M | $84.53M | $84.69M | 0.18% | 04/30/2025 | |
CDNA | CareDx | -$0.17 | $0.15 | $0.18 | 20.00% | $65.57M | $84.56M | $86.58M | 2.39% | 02/26/2025 | |
CDNA | CareDx | -$0.18 | $0.01 | $0.14 | 1300.00% | $67.19M | $80.53M | $82.88M | 2.92% | 11/04/2024 | |
CDNA | CareDx | -$0.18 | -$0.14 | $0.25 | 278.57% | $70.30M | $67.86M | $92.27M | 35.98% | 07/31/2024 | |
CDNA | CareDx | -$0.11 | -$0.19 | -$0.03 | 84.21% | $77.26M | $63.50M | $72.05M | 13.46% | 05/09/2024 | |
CDNA | CareDx | -$0.07 | -$0.27 | -$0.17 | 37.04% | $82.38M | $63.65M | $65.57M | 3.01% | 02/28/2024 | |
CDNA | CareDx | -$0.06 | -$0.39 | -$0.18 | 53.85% | $79.36M | $53.14M | $67.19M | 26.44% | 11/08/2023 | |
CDNA | CareDx | -$0.13 | -$0.31 | -$0.18 | 41.94% | $80.63M | $61.76M | $70.30M | 13.83% | 08/08/2023 | |
CDNA | CareDx | -$0.13 | -$0.11 | -$0.11 | 0.00% | $79.42M | $80.70M | $77.26M | -4.26% | 05/10/2023 | |
CDNA | CareDx | -$0.03 | -$0.09 | -$0.07 | 22.22% | $79.22M | $81.66M | $82.38M | 0.89% | 02/27/2023 | |
CDNA | CareDx | $0.07 | -$0.14 | -$0.06 | 57.14% | $75.59M | $82.62M | $79.36M | -3.95% | 11/03/2022 | |
CDNA | CareDx | $0.11 | -$0.11 | -$0.13 | -18.18% | $74.19M | $81.85M | $80.63M | -1.49% | 08/04/2022 | |
CDNA | CareDx | $0.14 | -$0.05 | -$0.13 | -160.00% | $67.40M | $78.92M | $79.42M | 0.63% | 05/05/2022 | |
CDNA | CareDx | $0.08 | $0.03 | -$0.03 | -200.00% | $58.64M | $78.09M | $79.22M | 1.45% | 02/24/2022 | |
CDNA | CareDx | $0.10 | $0.01 | $0.07 | 600.00% | $53.40M | $74.05M | $75.59M | 2.08% | 10/28/2021 | |
CDNA | CareDx | $0.04 | $0.02 | $0.11 | 450.00% | $41.80M | $67.55M | $74.19M | 9.83% | 07/29/2021 | |
CDNA | CareDx | $0.00 | — | $0.14 | — | $38.38M | $61.05M | $67.40M | 10.40% | 05/05/2021 | |
CDNA | CareDx | $0.04 | $0.02 | $0.08 | 300.00% | $35.82M | $55.51M | $58.64M | 5.65% | 02/24/2021 |
CareDx (CDNA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $0.28 | $0.04 | 600.0 % |
| Q2 | 2025-08-06 | $0.10 | $0.03 | 233.3 % |
| Q1 | 2025-04-30 | $0.09 | $0.07 | 28.6 % |
| Q4 | 2025-02-26 | $0.18 | $0.15 | 20.0 % |
CareDx (CDNA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $100.06M | $95.24M | 5.05 % |
| Q2 | 2025-08-06 | $86.68M | $90.63M | -4.35 % |
| Q1 | 2025-04-30 | $84.69M | $84.53M | 0.18 % |
| Q4 | 2025-02-26 | $86.58M | $84.56M | 2.39 % |
FAQ
When is CareDx (NASDAQ:CDNA) reporting earnings?
CareDx (CDNA) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 4, 2025 for Q3.
What were the latest earnings per share (EPS) for CareDx (NASDAQ:CDNA)?
CareDx (CDNA) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 4, 2025 for Q3 and the Actual EPS was $0.28, which beat the estimate of $0.04.
What were CareDx’s (NASDAQ:CDNA) revenues?
CareDx (CDNA) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 4, 2025 for Q3 and the Actual Revenue was $100.1M, which beat the estimate of $95.2M.
Browse earnings estimates, EPS, and revenue on all stocks.
